1. Home
  2. PODD vs VLTO Comparison

PODD vs VLTO Comparison

Compare PODD & VLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • VLTO
  • Stock Information
  • Founded
  • PODD 2000
  • VLTO 2023
  • Country
  • PODD United States
  • VLTO United States
  • Employees
  • PODD N/A
  • VLTO N/A
  • Industry
  • PODD Medical/Dental Instruments
  • VLTO Electrical Products
  • Sector
  • PODD Health Care
  • VLTO Industrials
  • Exchange
  • PODD Nasdaq
  • VLTO Nasdaq
  • Market Cap
  • PODD 21.5B
  • VLTO 22.2B
  • IPO Year
  • PODD 2007
  • VLTO N/A
  • Fundamental
  • Price
  • PODD $302.52
  • VLTO $96.79
  • Analyst Decision
  • PODD Strong Buy
  • VLTO Buy
  • Analyst Count
  • PODD 19
  • VLTO 10
  • Target Price
  • PODD $320.11
  • VLTO $110.10
  • AVG Volume (30 Days)
  • PODD 796.4K
  • VLTO 1.0M
  • Earning Date
  • PODD 08-07-2025
  • VLTO 07-24-2025
  • Dividend Yield
  • PODD N/A
  • VLTO 0.45%
  • EPS Growth
  • PODD 67.46
  • VLTO 8.36
  • EPS
  • PODD 5.55
  • VLTO 3.50
  • Revenue
  • PODD $2,198,900,000.00
  • VLTO $5,279,000,000.00
  • Revenue This Year
  • PODD $24.49
  • VLTO $6.03
  • Revenue Next Year
  • PODD $17.45
  • VLTO $4.67
  • P/E Ratio
  • PODD $54.39
  • VLTO $27.73
  • Revenue Growth
  • PODD 23.48
  • VLTO 4.70
  • 52 Week Low
  • PODD $173.00
  • VLTO $83.87
  • 52 Week High
  • PODD $329.33
  • VLTO $115.00
  • Technical
  • Relative Strength Index (RSI)
  • PODD 47.95
  • VLTO 44.49
  • Support Level
  • PODD $299.47
  • VLTO $96.85
  • Resistance Level
  • PODD $310.18
  • VLTO $98.22
  • Average True Range (ATR)
  • PODD 6.66
  • VLTO 1.29
  • MACD
  • PODD -3.22
  • VLTO -0.52
  • Stochastic Oscillator
  • PODD 25.46
  • VLTO 14.02

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About VLTO Veralto Corp

Veralto Corp is a provider of essential technology solutions that safeguard many of the world's most vital resources. The company operates in two segments: Water Quality and Product Quality & Innovation. Through the WQ segment, it improves the quality and reliability of water through brands including Hach, Trojan Technologies, and ChemTreat. Through the PQI segment, the company promotes consumer trust in products and helps enable product innovation through brands including Videojet, Linx, Esko, X-Rite, and Pantone.

Share on Social Networks: